Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cancers|April 30, 2021
Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AMLSalvatore Nicola Bertuccio, Laura Anselmi, Riccardo Masetti, et al.
Oncotarget|January 5, 2018
Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-AsparaginaseSalvatore Nicola Bertuccio, Salvatore Serravalle, Annalisa Astolfi, et al.
Oncotarget|November 3, 2014
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progressionAlessandro Poli, Giulia Ramazzotti, Alessandro Matteucci, et al.
Biochimica Et Biophysica Acta|October 7, 2014
Autophagy in acute leukemias: a double-edged sword with important therapeutic implicationsCecilia Evangelisti, Camilla Evangelisti, Francesca Chiarini, et al.
Frontiers in Genetics|October 28, 2021
hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 Mutation in MiceFabrizio Martelli, Paola Verachi, Maria Zingariello, et al.
Advances in Biological Regulation|May 14, 2014
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cellsAlberto M Martelli, Annalisa Lonetti, Francesca Buontempo, et al.
International Journal of Oncology|June 28, 2014
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review)Camilla Evangelisti, Cecilia Evangelisti, Francesca Chiarini, et al.
Expert Opinion on Therapeutic Targets|June 13, 2013
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemiaCamilla Evangelisti, Cecilia Evangelisti, Daniela Bressanin, et al.
Biochimica Et Biophysica Acta|September 4, 2015
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targetingFrancesca Chiarini, Annalisa Lonetti, Camilla Evangelisti, et al.
Oncotarget|April 15, 2015
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitorsAnnalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, et al.
Pageof 5